CA2470201A1 - Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis - Google Patents

Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis Download PDF

Info

Publication number
CA2470201A1
CA2470201A1 CA002470201A CA2470201A CA2470201A1 CA 2470201 A1 CA2470201 A1 CA 2470201A1 CA 002470201 A CA002470201 A CA 002470201A CA 2470201 A CA2470201 A CA 2470201A CA 2470201 A1 CA2470201 A1 CA 2470201A1
Authority
CA
Canada
Prior art keywords
compositions
skin
wrinkles
fine lines
hyperhidrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002470201A
Other languages
French (fr)
Other versions
CA2470201C (en
Inventor
Michelle Zheng Lu
Robert E. Kalafsky
Michele C. Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avon Products Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002552442A priority Critical patent/CA2552442A1/en
Publication of CA2470201A1 publication Critical patent/CA2470201A1/en
Application granted granted Critical
Publication of CA2470201C publication Critical patent/CA2470201C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Abstract

The present invention describes compositions and methods for treating, preventing and improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, wherein the compositions include limonoid constituents which inhibit acetylcholine release at neuromuscular junctions of skeletal muscle so as to relax the muscles involved with wrinkling, folding and creasing of skin, e.g., facial movement and expression. The limonoids preferably include the plant alkaloids toosendanin and azadirachtin. The compositions, which also are used to treat hyperhidrosis, are preferably applied to the skin, or are delivered by directed means to a site in need thereof.
CA002470201A 2002-12-31 2003-12-17 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis Expired - Fee Related CA2470201C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002552442A CA2552442A1 (en) 2002-12-31 2003-12-17 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/334,887 US6866856B2 (en) 2002-12-31 2002-12-31 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
US10/334,887 2002-12-31
PCT/US2003/040660 WO2004060326A1 (en) 2002-12-31 2003-12-17 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002552442A Division CA2552442A1 (en) 2002-12-31 2003-12-17 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis

Publications (2)

Publication Number Publication Date
CA2470201A1 true CA2470201A1 (en) 2004-06-30
CA2470201C CA2470201C (en) 2006-09-26

Family

ID=32655203

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002470201A Expired - Fee Related CA2470201C (en) 2002-12-31 2003-12-17 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis

Country Status (9)

Country Link
US (1) US6866856B2 (en)
EP (1) EP1471874A4 (en)
JP (1) JP2006514657A (en)
AU (1) AU2003303628B2 (en)
BR (1) BR0307124A (en)
CA (1) CA2470201C (en)
MX (1) MXPA04006896A (en)
PL (2) PL377443A1 (en)
WO (1) WO2004060326A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2617692T3 (en) * 2000-07-21 2017-06-19 Revance Therapeutics, Inc. Multi-component biological agent transport systems
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
US6916120B2 (en) * 2002-01-30 2005-07-12 Adc Telecommunications, Inc. Fiber optic connector and method
US20040131565A1 (en) * 2002-10-29 2004-07-08 Lee Letica Lipstick composition containing essential oils
US7476222B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US7477938B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7486989B2 (en) 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
US7507228B2 (en) 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US7477940B2 (en) 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7477939B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of treating a wound with galvanic generated electricity
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
CA2558676C (en) * 2004-03-03 2019-04-16 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
TR201815364T4 (en) 2004-03-03 2018-11-21 Revance Therapeutics Inc Topical application and transdermal distribution of botulinum toxins.
US20060135383A1 (en) * 2004-12-17 2006-06-22 Cossa Anthony J Cleansing compositions comprising polymeric emulsifiers and methods of using same
CA2588131C (en) * 2004-12-22 2014-02-11 Avon Products, Inc. Method and composition for reducing the appearance of wrinkles
US8022179B2 (en) * 2005-03-03 2011-09-20 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of an oligopeptide
WO2006094263A2 (en) * 2005-03-03 2006-09-08 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
ES2259928B1 (en) 2005-04-08 2007-11-01 Lipotec, S.A. COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION THAT INCLUDES PEPTIDES DERIVED FROM ENCEPHALINES TO REDUCE AND / OR ELIMINATE FACIAL WRINKLES.
US20070065515A1 (en) * 2005-09-22 2007-03-22 Key Douglas J Methods and compositions for treating skin lines and wrinkles and improving skin quality
CN101355962A (en) * 2005-11-17 2009-01-28 雷文斯治疗公司 Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
US7544375B1 (en) 2006-06-12 2009-06-09 Swiss Skin Repair, Inc. Composition
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
NZ598039A (en) * 2006-12-29 2013-08-30 Revance Therapeutics Inc Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
NZ598159A (en) * 2006-12-29 2013-08-30 Revance Therapeutics Inc Transport molecules using reverse sequence hiv-tat polypeptides
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
ES2562205T3 (en) * 2007-04-17 2016-03-03 Codman & Shurtleff, Inc. Resveratrol curcumin hybrids
RU2471492C2 (en) * 2007-09-28 2013-01-10 Джонсон Энд Джонсон Конзьюмер Компаниз, Инк. Electrogenerating particles and use thereof
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
US8150525B2 (en) * 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
CN102149398B (en) * 2008-09-11 2013-12-04 I·B·R·以色列生物科技研究有限公司 Leucojum bulb extracts and use thereof
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
KR101226660B1 (en) 2009-06-19 2013-01-25 일동제약주식회사 Composition for preventing or treating dementia comprising toosendanin or extracts of Melia azedarach(Melia toosendan)
JP5616045B2 (en) * 2009-10-05 2014-10-29 花王株式会社 Ceramide production promoter and moisturizer
CN102686229B (en) * 2009-10-05 2015-07-22 花王株式会社 Ceramide production enhancer and moisturizing agent
JP5689247B2 (en) * 2010-04-28 2015-03-25 花王株式会社 Ceramide production promoter and moisturizer
ES2617760T3 (en) * 2009-11-13 2017-06-19 Johnson & Johnson Consumer Inc. Galvanic device for skin treatment
JP2011105666A (en) * 2009-11-19 2011-06-02 Kao Corp Dopa oxidase activity inhibitor and whitening agent
US8747383B2 (en) * 2009-12-18 2014-06-10 University Medical Pharmaceuticals Corp. Process and system for iontophoretic wrinkle reduction
KR20110091461A (en) * 2010-02-05 2011-08-11 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 Lip compositions comprising galvanic particulates
BR112012022106A2 (en) * 2010-03-01 2016-10-25 Johnson & Johnson Consumer skin care composition having a desirable color volume
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition
JP2012167023A (en) * 2011-02-09 2012-09-06 Kao Corp Ceramide production promoter, humectant, and skin care preparation for external use
JP2012167022A (en) * 2011-02-09 2012-09-06 Kao Corp Ceramide production promoter, humectant, and skin care preparation for external use
EP2802337B2 (en) 2011-11-07 2021-01-20 Feng Tian Peptide-based compounds as inhibitors of neurotransmitter secretion
KR101723084B1 (en) * 2014-06-23 2017-04-04 대한민국 Cosmetic composition for improving skin wrinkle or enhancing skin elasticity comprising nomilin or pharmaceutically acceptable salts thereof
US20190015467A1 (en) * 2017-07-12 2019-01-17 Kao Corporation Agent for preventing or ameliorating uneven skin tone
JP2021527085A (en) 2018-06-13 2021-10-11 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ Peptide with inhibitory activity against nerve cell exocytosis

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5228854B2 (en) * 1974-06-27 1977-07-29
CH624011A5 (en) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US5223262A (en) * 1989-02-23 1993-06-29 University Of Utah Transdermal delivery system utilizing one way membranes
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5376363A (en) * 1991-05-03 1994-12-27 Bristol-Myers Squibb Company Clear gelled antiperspirant stick composition
US5370873A (en) * 1992-09-11 1994-12-06 Udeinya; Iroka J. Therapeutic compounds derived from the neem tree
JPH08508717A (en) * 1993-02-09 1996-09-17 タルサ・フォート・ファーマシー・エンタープライゼズ・インコーポレーテッド Method for promoting hair growth by cationic derivative of minoxidil using iontophoresis
USH1541H (en) 1993-07-21 1996-06-04 Holla; Kadambar S. Method for producing azadirachtin concentrates from neem seed materials
JP3541049B2 (en) * 1993-11-12 2004-07-07 御木本製薬株式会社 Hyaluronidase inhibitor
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5500209A (en) * 1994-03-17 1996-03-19 The Mennen Company Deodorant and antiperspirant compositions containing polyamide gelling agent
FR2747308B1 (en) * 1996-04-11 1998-07-10 Shrivastava Ravi ASSOCIATION OF MARGOUSIER, (-) HYDROXYCITRATE AND CERAMIDES AND COMPOSITIONS CONTAINING THEM
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5932229A (en) * 1996-04-25 1999-08-03 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
US6338855B1 (en) * 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
US5885600A (en) * 1997-04-01 1999-03-23 Burlington Bio-Medical & Scientific Corp. Natural insect repellent formula and method of making same
DE69808790T3 (en) * 1997-09-12 2009-07-16 The Procter & Gamble Co., Cincinnati SKIN CLEANSING AND CONDITIONING ITEMS FOR SKIN AND HAIR
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
JP2002528400A (en) * 1998-10-26 2002-09-03 ユニバーシティー オブ マサチューセッツ Skin treatment with adenosine or adenosine analogues
DE19852981A1 (en) * 1998-11-17 2000-05-18 Martin Schmidt Use of botulinum toxin and its derivatives in topical treatment compositions to influence acetylcholine-dependent body functions
FR2787996B1 (en) * 1998-12-30 2002-05-10 Dior Christian Parfums COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AN ACTIVE INGREDIENT THAT STIMULATES THE SYNTHESIS OF HSP 32 PROTEIN IN THE SKIN AND COSMETIC PROCESSING METHOD
FR2793681B1 (en) * 1999-05-18 2001-06-22 Oreal USE OF AT LEAST ONE INHIBITOR OF AT LEAST ONE CALCIUM CHANNEL IN THE TREATMENT OF WRINKLES
BR0013272B1 (en) * 1999-08-13 2013-10-15 Use of a steroidal aromatase inhibitor
CN1306750A (en) * 2000-01-28 2001-08-08 武长安 Herbal pesticide
US6753315B2 (en) 2000-02-24 2004-06-22 Brown University Research Foundation α-bungarotoxin molecules and uses thereof
IT1318425B1 (en) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro USE OF RESVERATROL FOR THE TREATMENT OF DESQUAMATIVE ECZEMA, ACNE AND PSORIASIS.
DE10021560A1 (en) * 2000-05-03 2001-11-08 Promelia Produkte Mit Naturext Skin care composition used as insect repellent action, contains combination of extracts of neem tree and cloves
JP2001316239A (en) * 2000-05-10 2001-11-13 Mikimoto Pharmaceut Co Ltd Skin care preparation
JP3928153B2 (en) * 2001-01-19 2007-06-13 コスメディ製薬株式会社 Sheet patch
US20030091665A1 (en) * 2001-11-09 2003-05-15 Avon Products, Inc Topical cosmetic composition with skin rejuvenation benefits
US20030124205A1 (en) * 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same

Also Published As

Publication number Publication date
PL395231A1 (en) 2011-09-12
US6866856B2 (en) 2005-03-15
MXPA04006896A (en) 2004-12-06
AU2003303628A1 (en) 2004-07-29
AU2003303628B2 (en) 2006-03-09
US20040127556A1 (en) 2004-07-01
CA2470201C (en) 2006-09-26
EP1471874A1 (en) 2004-11-03
EP1471874A4 (en) 2007-06-27
PL377443A1 (en) 2006-02-06
BR0307124A (en) 2004-12-07
WO2004060326A1 (en) 2004-07-22
JP2006514657A (en) 2006-05-11

Similar Documents

Publication Publication Date Title
CA2470201A1 (en) Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
CA2588128C (en) Compositions and methods of their use for improving the condition and appearance of skin
WO2006068779A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
WO2008150490A3 (en) Uses and compositions for treatment of psoriasis and crohn's disease
MX2007007409A (en) Rapamycin derivatives and the uses thereof in the treatment of neurological disorders.
EP3272329A3 (en) Compositions and methods for stimulation magp-1 to improve the appearance of skin
WO2006068777A3 (en) Use of natural plant extracts in cosmetics compositions
BR0309855A (en) Carbamate substituted pyrazolpyridines
EP2286838A3 (en) Treatment of obesity and related disorders
WO2007133249A3 (en) Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
HK1109070A1 (en) Treatment articles capable of conforming to an underlying shape
CA2306560A1 (en) Topical antifungal composition
TW200600092A (en) Topical slimming preparation and a cosmetic containing a carnitine derivative
MX2010004886A (en) Method of improving skin appearance using treated macroscopic particles.
BR0110185A (en) Petrol modified nonwoven fabrics, and topical treatment for nonwoven fabric
IL132293A0 (en) Use of lactoferin in the treatment of allergen induced disorders
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
WO2007070779A3 (en) A method to treat premature ejaculation in humans
WO2008145692A3 (en) Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression
WO2006086693A3 (en) Medical devices
WO2006009975A3 (en) Histamine to treat disorders affecting muscle function
WO2004017924A3 (en) Methods of treating involuntary facial spasms and facial wrinkles
WO2004093722A3 (en) Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
MX2009002224A (en) Xanthoxyline-based composition and cosmetic use thereof.
MXPA03010473A (en) Wet-skin treatment compositions.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201217